Effect of Rifampicin on the Pharmacokinetics of Selexipag, an Oral Prostacyclin Receptor Agonist, and Its Active Metabolite in Healthy Male Subjects
Clinical Therapeutics - United States
doi 10.1016/j.clinthera.2017.05.073
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2017
Authors
Publisher
Elsevier BV